Belite Bio, Inc.

Belite Bio, Inc. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapeutics targeting significant unmet needs in metabolic diseases. A key focus area for Belite Bio is the development of innovative treatments for conditions such as Non-Alcoholic Steatohepatitis (NASH) and eye diseases like Stargardt Disease. By leveraging cutting-edge research in the field of mitochondrial dysfunctions and genetic disorders, the company aims to provide groundbreaking solutions that address the root causes of these challenging health issues. Belite Bio is influential in the healthcare sector, particularly within the biotechnology segment, as it engages in pioneering research that could lead to life-changing therapies. As a participant in the development of advanced biopharma solutions, Belite Bio plays a vital role in enhancing the treatment landscape, offering hope for improved patient outcomes and contributing to the advancement of medical science in metabolic and ocular disease sectors.